Delivery Order SPE2DB24D2105-SPE2DB25FAQFJ
- Not listed
- The Defense Logistics Agency awarded a $7,438.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with a completion date of September 4, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran...
- The Defense Logistics Agency awarded a $15,307.90 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-count units) with an ultimate completion date of April 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging) valued at $21,040.94, with an ultimate completion date of June 30, 2025. This non-set-aside award represents a competitive procurement supporting the agency's pharmaceutical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $47,140.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of RINVOQ ER 30 mg in unit packs of 30, with an ultimate completion date of August 5, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a key...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $6,223.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-tablet units) on April 29, 2025, with a completion date of April 30, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $26,581.58 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 1, 2025, with an ultimate completion date of July 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.19 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.17 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical delivery under the company's broader federal contracting relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-tablet units) valued at $24,917.61 under a firm fixed-price contract type. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQFJDelivery Order
The Defense Logistics Agency awarded a $57,586.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units), with an ultimate completion date of September 16, 2025. This non-set-aside contract represents a competitive award issued to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary supplier of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract structure reflects the Defense Logistics Agency's Medical Supply Chain approach, which leverages prime vendor agreements to efficiently distribute critical medications and medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.6k | 9/15/25 |